PMID- 11278679 OWN - NLM STAT- MEDLINE DCOM- 20010705 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 276 IP - 20 DP - 2001 May 18 TI - Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. PG - 17301-6 AB - Cognitive impairment is a major feature of Alzheimer's disease and is accompanied by beta-amyloid (Abeta) deposition. Transgenic animal models that overexpress Abeta exhibit learning and memory impairments, but neuronal degeneration is not a consistent characteristic. We report that levels of Abeta-(1-42), which do not compromise the survival of cortical neurons, may indeed interfere with functions critical for neuronal plasticity. Pretreatment with Abeta-(1-42), at sublethal concentrations, resulted in a suppression of cAMP-response element-binding protein (CREB) phosphorylation, induced by exposure to either 30 mm KCl or 10 microm N-methyl-d-aspartate. The effects of Abeta-(1-42) seem to involve mechanisms unrelated to degenerative changes, since Abeta-(25-35), a toxic fragment of Abeta, at sublethal concentrations did not interfere with activity-dependent CREB phosphorylation. Furthermore, caspase inhibitors failed to counteract the Abeta-(1-42)-evoked suppression of CREB activation. Abeta-(1-42) also interfered with events downstream of activated CREB. The Abeta-(1-42) treatment suppressed the activation of the cAMP response element-containing brain-derived neurotrophic factor (BDNF) exon III promoter and the expression of BDNF exon IIII mRNA induced by neuronal depolarization. In view of the critical role of CREB and BDNF in neuronal plasticity, including learning and memory, the observations indicate a novel pathway through which Abeta may interfere with neuronal functions and contribute to cognitive deficit in Alzheimer's disease before the stage of massive neuronal degeneration. FAU - Tong, L AU - Tong L AD - University of California, Irvine Institute for Brain Aging and Dementia, Irvine, California 92697-4540, USA. tongl@uci.edu FAU - Thornton, P L AU - Thornton PL FAU - Balazs, R AU - Balazs R FAU - Cotman, C W AU - Cotman CW LA - eng GR - R01-NS-40953/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20010226 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Amino Acid Chloromethyl Ketones) RN - 0 (Amyloid beta-Peptides) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Cysteine Proteinase Inhibitors) RN - 0 (Peptide Fragments) RN - 0 (RNA, Messenger) RN - 0 (amyloid beta-protein (1-42)) RN - 0 (amyloid beta-protein (25-35)) RN - 0 (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) RN - 6384-92-5 (N-Methylaspartate) RN - 660YQ98I10 (Potassium Chloride) SB - IM MH - Amino Acid Chloromethyl Ketones/pharmacology MH - Amyloid beta-Peptides/*pharmacology MH - Animals MH - Brain-Derived Neurotrophic Factor/*genetics MH - Cell Survival/drug effects MH - Cells, Cultured MH - Cerebral Cortex/cytology/physiology MH - Cyclic AMP Response Element-Binding Protein/drug effects/*metabolism MH - Cysteine Proteinase Inhibitors/pharmacology MH - Embryo, Mammalian MH - Exons MH - Gene Expression Regulation/drug effects MH - N-Methylaspartate/pharmacology MH - Neurons/cytology/drug effects/*physiology MH - Peptide Fragments/*pharmacology MH - Phosphorylation MH - Potassium Chloride/pharmacology MH - Promoter Regions, Genetic MH - RNA, Messenger/genetics MH - Rats MH - Signal Transduction/drug effects/*physiology MH - Transcription, Genetic/drug effects/*physiology EDAT- 2001/03/30 10:00 MHDA- 2001/07/06 10:01 CRDT- 2001/03/30 10:00 PHST- 2001/03/30 10:00 [pubmed] PHST- 2001/07/06 10:01 [medline] PHST- 2001/03/30 10:00 [entrez] AID - S0021-9258(19)31914-3 [pii] AID - 10.1074/jbc.M010450200 [doi] PST - ppublish SO - J Biol Chem. 2001 May 18;276(20):17301-6. doi: 10.1074/jbc.M010450200. Epub 2001 Feb 26.